123 related articles for article (PubMed ID: 23047828)
21. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand.
Jaruratanasirikul S; Thammaratchuchai S; Puwanant M; Mo-Suwan L; Sriplung H
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1267-1275. PubMed ID: 27740930
[TBL] [Abstract][Full Text] [Related]
22. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
Han XY; Ji LN; Zhou XH
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
[TBL] [Abstract][Full Text] [Related]
23. Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes.
Kuwano T; Miura SI; Norimatsu K; Arimura T; Shiga Y; Tomita S; Nakayama A; Matsuo Y; Imaizumi S; Saku K
Hypertens Res; 2017 Mar; 40(3):271-276. PubMed ID: 27733768
[TBL] [Abstract][Full Text] [Related]
24. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.
Faerch K; Vaag A; Holst JJ; Hansen T; Jørgensen T; Borch-Johnsen K
Diabetes Care; 2009 Mar; 32(3):439-44. PubMed ID: 19056613
[TBL] [Abstract][Full Text] [Related]
25. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
26. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
27. Influence of endogenous hyperinsulinism on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance.
Jiao S; Kameda K; Matsuzawa Y; Kubo M; Nonaka K; Tarui S
Atherosclerosis; 1986 Jun; 60(3):279-86. PubMed ID: 3730047
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein composition in individuals with impaired glucose tolerance.
Capaldo B; Tutino L; Patti L; Vaccaro O; Rivellese A; Riccardi G
Diabetes Care; 1983; 6(6):575-8. PubMed ID: 6653315
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding changes in body weight.
Igarashi Y; Mita T; Mizuno R; Watada H; Tanaka Y; Kawamori R; Hirose T
Endocr J; 2005 Dec; 52(6):683-9. PubMed ID: 16410659
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
Kopprasch S; Pietzsch J; Kuhlisch E; Graessler J
J Clin Endocrinol Metab; 2003 Apr; 88(4):1711-6. PubMed ID: 12679462
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.
Goff DC; D'Agostino RB; Haffner SM; Saad MF; Wagenknecht LE
Diabetes Care; 2000 Jul; 23(7):1006-11. PubMed ID: 10895855
[TBL] [Abstract][Full Text] [Related]
33. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study.
Modan M; Halkin H; Lusky A; Segal P; Fuchs Z; Chetrit A
Arteriosclerosis; 1988; 8(3):227-36. PubMed ID: 3285821
[TBL] [Abstract][Full Text] [Related]
34. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
Jain SK; McVie R; Meachum ZD; Smith T
Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
[TBL] [Abstract][Full Text] [Related]
35. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
36. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
[TBL] [Abstract][Full Text] [Related]
38. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Osei K; Gaillard T; Schuster DP
Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
[TBL] [Abstract][Full Text] [Related]
39. The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.
Pan ZQ; Xie D; Choudhary V; Seremwe M; Tsai YY; Olala L; Chen X; Bollag WB
Mol Cell Endocrinol; 2014 Aug; 394(1-2):119-28. PubMed ID: 25038520
[TBL] [Abstract][Full Text] [Related]
40. Adrenocortical function in young adults with diabetes mellitus type 1.
Simunkova K; Hampl R; Hill M; Kriz L; Hrda P; Janickova-Zdarska D; Zamrazil V; Vrbikova J; Vondra K
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):35-41. PubMed ID: 20433924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
